Cargando…
PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancer
Studies of PDPN in cancers have focused on the interactions with palates through the binding with CECL-2 which mainly express on palates and immune cells, while little is known on its interactions with immune cells. PDPN expression in cancers was analyzed through Oncomine, GEPIA, and TIMER database....
Autores principales: | Hu, Liya, Zhang, Peng, Sun, Wei, Zhou, Lei, Chu, Qian, Chen, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220208/ https://www.ncbi.nlm.nih.gov/pubmed/32384443 http://dx.doi.org/10.1097/MD.0000000000019957 |
Ejemplares similares
-
LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022) -
LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022) -
Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer
por: Liu, Kai, et al.
Publicado: (2015) -
CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma
por: Zhang, Jingxin, et al.
Publicado: (2022) -
Prognostic significance and immune infiltration of microenvironment-related signatures in pancreatic cancer
por: Lu, Qian, et al.
Publicado: (2021)